
About the Optic Neuropathy Session
Optic neuropathy refers to damage or disease affecting the optic nerve, crucial for transmitting visual information from the eye to the brain. This condition can lead to vision loss or impairment and may result from various causes, including trauma, inflammation (such as in optic neuritis), vascular disorders (like ischemic optic neuropathy), toxins, and systemic diseases (such as diabetes or multiple sclerosis). Symptoms can vary widely depending on the underlying cause but commonly include blurred vision, dimming of vision, visual field defects, and color vision changes.
Diagnosis involves a thorough eye examination, imaging studies (like MRI or CT scans), and sometimes additional tests like visual field testing or blood tests to identify the underlying cause. Treatment aims to address the specific cause; for example, inflammation might be treated with corticosteroids, while managing vascular risk factors can help in ischemic cases. Early detection and prompt treatment are crucial in optimizing outcomes for patients with optic neuropathy.
Topics Covered in Optic Neuropathy
Arteritic & Non-Arteritic AION
Compressive Lesions
Toxic & Nutritional Causes
LHON & Dominant Optic Atrophy
Traumatic Optic Neuropathy
OCT Nerve Fiber Analysis
Featured Speakers — Optic Neuropathy 2027

Recent Research Presented at Optic Neuropathy Sessions
Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Leber Hereditary Optic Neuropathy (LHON) is a rare, maternally inherited mitochondrial genetic disorder characterized by sudden, painless vision loss, and represents a significant unmet medical need.…
Analysis of peripapillary and macular blood flow in non arthritic ischemic optic neuropathy with optic coherence tomography angiography
Our aim in this study is to evaluate peripapillary and macular blood flow in patients diagnosed with Non-Arteritic Ischemic Optic Neuropathy (NA-AION) and to compare them with the healthy eyes of the…
Lumevoq gene therapy in leber hereditary optic neuropathy
Leber Hereditary Optic Neuropathy (LHON) is a rare, maternally inherited mitochondrial genetic disorder characterized by sudden, painless vision loss. The disease has a significant unmet medical need…
Second-eye non-arteritic anterior ischaemic optic neuropathy following cataract surgery: Diagnostic uncertainty in patients with polymyalgia rheumatica
Purpose: To report a case of second-eye Non-Arteritic Anterior Ischaemic Optic Neuropathy (NAION) occurring shortly after uncomplicated cataract surgery, and to highlight the diagnostic and…
Lumevoq gene therapy in leber hereditary optic neuropathy
Leber hereditary optic neuropathy (LHON) is a rare, maternally inherited mitochondrial genetic disease with a high unmet medical need. Three primary point mutations in the mtDNA are responsible for…
Lumevoq gene therapy in leber hereditary optic neuropathy
Leber hereditary optic neuropathy (LHON) is a rare, maternally inherited mitochondrial genetic disease with a continued high unmet medical need. Three primary point mutations in the mtDNA are…
Related Scientific Sessions at IOC 2027
Why Attend the Optic Neuropathy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Optic Neuropathy work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Optic Neuropathy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Optic Neuropathy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Optic Neuropathy Conference 2027 — FAQs
What is the Optic Neuropathy track at IOC 2027?
The Optic Neuropathy track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Optic Neuropathy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Optic Neuropathy sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Optic Neuropathy are all welcome — whether presenting or attending.
Can I present my research in the Optic Neuropathy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Optic Neuropathy sessions?
Yes. IOC 2027 is a hybrid conference — attend the Optic Neuropathy track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
